Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by Kaiseron Jun 17, 2021 9:54am
67 Views
Post# 33401327

RE:RE:RE:RE:Like a Husband and Wife

RE:RE:RE:RE:Like a Husband and Wife

This stock was under .10 before the covid pump 

Last news that hit Friday... says it all.  Direct quote.
 

Sona Nanotech (SONA) is discontinuing the clinical trial of its COVID-19 rapid, antigen saliva test after a review of the initial results.

The decision to discontinue the trial is due to inadequate test sensitivity with clinical saliva samples and challenges with patient recruitment and enrollment, as the local prevalence of the virus has been significantly reduced.

Dude51 wrote: Smoke another one shitt for brains. How do you know I bought at 9 dollars, where did you get that info? You never got it from any of my postings so it's just more BS from a tiny mind again. Get a life loser.  I have not sold and therefore have not lost a cent and will wait for the turn around as I did not read or hear anything that this company is packing it in. Maybe you could provide a link to this info that spew/insinuate?

 

<< Previous
Bullboard Posts
Next >>